# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA619870 | F | Inhibition of oxidation of arachidonic acid by human 5-Lipoxygenase using spectrophotometric assay | Homo sapiens | 10 | assay format | Scientific Literature | ||
2. | ALA620874 | B | Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO) | 8 | single protein format | Scientific Literature | |||
3. | ALA622829 | A | Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
4. | ALA874448 | A | Bioavailability in rat (Sprague-Dawley) (male) | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
5. | ALA636486 | A | Plasma half-life in dogs in the presence of PEG 400/water(3:1) | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
6. | ALA636488 | A | Plasma half-life in rats in the presence of PEG 400/water(3:1) | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
7. | ALA671165 | F | Ex Vivo generation of LTB4 by whole blood stimulated with calcium ionophore A-23187 in anesthetized dogs | Canis lupus familiaris | 2 | organism-based format | Scientific Literature | ||
8. | ALA671198 | F | Inhibition of urinary LTE4 levels in dogs | Canis lupus familiaris | 2 | organism-based format | Scientific Literature | ||
9. | ALA689332 | F | Compound was evaluated for in vitro inhibition of leukotriene (LTB4) in human peripheral blood polymorphonuclear leukocytes (HPMN) | Homo sapiens | 8 | assay format | Scientific Literature | ||
10. | ALA702326 | F | Compound was evaluated for in vitro inhibition of leukotriene (LTB4) in human whole blood (HWB) | Homo sapiens | 8 | organism-based format | Scientific Literature | ||
11. | ALA702328 | F | Compound was evaluated for production of leukotriene B4 in human whole blood (HWB) activated with ionophore A-23187. | Homo sapiens | 11 | organism-based format | Scientific Literature | ||
12. | ALA878772 | F | Compound was evaluated for production of leukotriene B4 in Ca+2 -ionophore -activated human polymorphonuclear (HPMN) leukocytes. | Homo sapiens | 12 | organism-based format | Scientific Literature | ||
13. | ALA871802 | F | compound was tested for inhibition of ovalbumin- induced dyspnea in inbred hyperreactive rats at 0.5 mg/kg | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
14. | ALA798073 | F | Inhibition of LTB4 levels in rat pleural exudates | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
15. | ALA804756 | F | Compound was tested for inhibition of Ascaris -induced bronchoconstriction in sheep at 2.5 ug/kg intravenous administration | Ovis aries | 2 | organism-based format | Scientific Literature | ||
16. | ALA805590 | F | Compound was tested for inhibition of Ascaris -induced bronchoconstriction in squirrel monkeys | Cercopithecidae | 2 | assay format | Scientific Literature | ||
17. | ALA5247059 | A | Oral bioavailability in dog | Canis lupus familiaris | 7 | organism-based format | Scientific Literature | ||
18. | ALA5247062 | A | Oral bioavailability in rat | Rattus norvegicus | 16 | organism-based format | Scientific Literature | ||
19. | ALA5247076 | F | Inhibition of Leukotriene B4 production in human whole blood | Homo sapiens | 6 | organism-based format | Scientific Literature | ||
20. | ALA5247078 | A | Cmax in rat plasma at 20 mg/kg, po | Rattus norvegicus | 3 | organism-based format | Scientific Literature |